These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 4346144
41. Effect of prostaglandins E 1 , E 2 and A 2 on vascular resistance and responses to noradrenaline, nerve stimulation and angiotensin in the dog hindlimb. Kadowitz PJ. Br J Pharmacol; 1972 Nov; 46(3):395-400. PubMed ID: 4348179 [Abstract] [Full Text] [Related]
42. The effects of intraportal injections of noradrenaline, adrenaline, vasopressin and angiotensin on the hepatic portal vascular bed of the dog: marked tachyphylaxis to angiotensin. Richardson PD, Withrington PG. Br J Pharmacol; 1977 Feb; 59(2):293-301. PubMed ID: 837016 [Abstract] [Full Text] [Related]
43. The effect of hepatic arterial injection of contrast medium, blood, and saline on hepatic artery flow. Itzchak Y, Groszmann RJ, Glickman MG. Invest Radiol; 1978 Feb; 13(6):528-32. PubMed ID: 755031 [No Abstract] [Full Text] [Related]
44. Conversion of angiotensin I into angiotensin II in the isolated perfused rat kidney. Hofbauer KG, Zschiedrich H, Rauh W, Gross F. Clin Sci; 1973 May; 44(5):447-56. PubMed ID: 4350390 [No Abstract] [Full Text] [Related]
45. Canine cerebrovascular response to nitroglycerin, acetylcholine, 5-hydroxytryptamine, and angiotensin. Lowe RF, Gilboe DD. Am J Physiol; 1973 Dec; 225(6):1333-8. PubMed ID: 4357328 [No Abstract] [Full Text] [Related]
47. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric oxide and bradykinin in conductance and resistance arteries. Sudhir K, Chou TM, Hutchison SJ, Chatterjee K. Circulation; 1996 May 01; 93(9):1734-9. PubMed ID: 8653880 [Abstract] [Full Text] [Related]
48. The inhibition by glucagon of the vasoconstrictor actions of noradrenaline, angiotensin and vasopressin on the hepatic arterial vascular bed of the dog. Richardson PD, Withrington PG. Br J Pharmacol; 1976 May 01; 57(1):93-102. PubMed ID: 1276544 [Abstract] [Full Text] [Related]
49. Prostaglandin E1: its effects on hepatic circulation in dogs. Geumei A, Bashour FA, Swamy BV, Nafrawi AG. Pharmacology; 1973 May 01; 9(6):336-47. PubMed ID: 4746889 [No Abstract] [Full Text] [Related]
50. Intrarenal role of angiotensin II. Homeostatic regulation of renal blood flow in the dog. Freeman RH, Davis JO, Vitale SJ, Johnson JA. Circ Res; 1973 Jun 01; 32(6):692-8. PubMed ID: 4351766 [No Abstract] [Full Text] [Related]
54. The vasodilator actions of isoprenaline, histamine, prostaglandin E2, glucagon and secretin on the hepatic arterial vascular bed of the dog. Richardson PD, Withrington PG. Br J Pharmacol; 1976 Aug 01; 57(4):581-8. PubMed ID: 963344 [Abstract] [Full Text] [Related]
55. Systemic hemodynamic responses to chronic angiotensin II infusion into the renal artery of dogs. Fitzgerald SM, Stevenson KM, Evans RG, Anderson WP. Am J Physiol; 1997 Dec 01; 273(6):R1980-9. PubMed ID: 9435652 [Abstract] [Full Text] [Related]
56. Interaction between angiotensin II and nitric oxide in control of renal hemodynamics in conscious dogs. Alberola AM, Salazar FJ, Nakamura T, Granger JP. Am J Physiol; 1994 Dec 01; 267(6 Pt 2):R1472-8. PubMed ID: 7810755 [Abstract] [Full Text] [Related]